Correlation Between Effector Therapeutics and ZyVersa Therapeutics
Can any of the company-specific risk be diversified away by investing in both Effector Therapeutics and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Effector Therapeutics and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Effector Therapeutics and ZyVersa Therapeutics, you can compare the effects of market volatilities on Effector Therapeutics and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Effector Therapeutics with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Effector Therapeutics and ZyVersa Therapeutics.
Diversification Opportunities for Effector Therapeutics and ZyVersa Therapeutics
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Effector and ZyVersa is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Effector Therapeutics and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Effector Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Effector Therapeutics are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Effector Therapeutics i.e., Effector Therapeutics and ZyVersa Therapeutics go up and down completely randomly.
Pair Corralation between Effector Therapeutics and ZyVersa Therapeutics
Given the investment horizon of 90 days Effector Therapeutics is expected to generate 0.51 times more return on investment than ZyVersa Therapeutics. However, Effector Therapeutics is 1.96 times less risky than ZyVersa Therapeutics. It trades about 0.07 of its potential returns per unit of risk. ZyVersa Therapeutics is currently generating about -0.13 per unit of risk. If you would invest 178.00 in Effector Therapeutics on February 21, 2024 and sell it today you would earn a total of 9.00 from holding Effector Therapeutics or generate 5.06% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Effector Therapeutics vs. ZyVersa Therapeutics
Performance |
Timeline |
Effector Therapeutics |
ZyVersa Therapeutics |
Effector Therapeutics and ZyVersa Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Effector Therapeutics and ZyVersa Therapeutics
The main advantage of trading using opposite Effector Therapeutics and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Effector Therapeutics position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Effector Therapeutics | ZyVersa Therapeutics vs. AVROBIO | ZyVersa Therapeutics vs. Immix Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |